Truist Securities Maintains Buy on Compugen, Raises Price Target to $5
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Asthika Goonewardene has maintained a Buy rating on Compugen (NASDAQ:CGEN) and raised the price target from $4 to $5.
March 08, 2024 | 2:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Truist Securities maintains a Buy rating on Compugen and increases the price target from $4 to $5.
The upgrade in price target by a reputable analyst firm like Truist Securities typically signals a positive outlook on the stock, suggesting potential upside. This can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100